Global Health IPO

Global Health Limited is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity and operating revenues amongst the players that operate in the North and East regions of India (as of and for the financial year ended March 31, 2022). The company operates in key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology (according to CRISIL Report).

Under the “Medanta” brand, the company has a network of five hospitals currently in operation (Gurugram, Indore, Ranchi, Lucknow and Patna) and one hospital (Noida), which is under construction.

The company is founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon, awarded with the Padma Bhushan and the Padma Shri, the third and fourth-highest civilian awards in India.

In Fiscal 2021, the company expanded the outpatient department pharmacies in-house at the Gurugram, Lucknow, Indore and Ranchi hospitals, and launched outpatient department pharmacy at south Delhi clinic and home care services in Gurugram and New Delhi. Further expansion happened with the company’s home-care services, which have scaled up the telemedicine and remote delivery of healthcare services, and the monthly average consultation via video and telephone in Gurugram increased by 1,419.33% from 419 in Fiscal 2020 to 6,366 in Fiscal 2021 and by 33.60% to 8,505 in Fiscal 2022, and 5,070 in the three months ended June 30, 2022.

In Fiscals 2020, 2021 and 2022 and the three months ended June 30, 2021 and 2022, the company generated income from healthcare services of Rs 14,805.71 million, Rs 14,178.41 million, Rs 21,003.95 million, Rs 4,732.10 million and Rs 5,960.89 million, respectively.